NCT00569127 · Interventional trial
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Overall registry status Active not recruiting
Phase 3
Conditions Colorectal Neuroendocrine Tumor G1, Gastric Neuroendocrine Tumor G1, Neuroendocrine Neoplasm, Neuroendocrine Tumor, Neuroendocrine Tumor G2
Delaware Valley sites
- Cooper Hospital University Medical Center · Camden, NJ · Camden County
- Jennersville Regional Hospital · West Grove, PA · Chester County
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory